The IARC TP53 database: New online mutation analysis and recommendations to users

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463

p53 and Human Cancer: The First Ten Thousand Mutations

Hainaut, P. L., & Hollstein, M. C. (1999) · Advances in cancer research · doi:10.1016/s0065-230x(08)60785-x · Cited by 999

Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome

Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M. L., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 899

Database of p53 gene somatic mutations in human tumors and cell lines.

Hollstein, M. C., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sørlie, T., Hovig, E. J., Smith‐Sørensen, B., Montesano, R., & Harris, C. C. (1994) · Europe PMC (PubMed Central) · Cited by 858

Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73

Strano, S., Munarriz, E. R., Rossi, M., Cristofanelli, B., Shaul, Y., Castagnoli, L., Levine, A. J., Sacchi, A., Cesareni, G., Oren, M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003360200 · Cited by 241

p53 gene mutation: software and database

Béroud, C. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.1.147 · Cited by 185

p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition.

Vahteristo, P., Tamminen, A., Karvinen, P., Eerola, H., Eklund, C., Aaltonen, L. A., BLOMQVIST, C. P., Aittomäki, K., & Nevanlinna, H. A. (2001) · PubMed · Cited by 180

p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer

Hussain, S. P., & Harris, C. C. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s1383-5742(99)00028-9 · Cited by 164

p53 and the Li-Fraumeni syndrome

Malkin, D. M. (1993) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(93)90233-c · Cited by 153

p53 gene mutation: software and database

Béroud, C. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.200 · Cited by 149

TP53 Codon 72 Polymorphism and Risk of Acute Leukemia

Dunna, N. R., Vure, S., Sailaja, K., Surekha, D., Digumarti, R., Rajappa, S. J., & Vishnupriya, S. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.1.349 · Cited by 25

Analysis of transactivation capability and conformation of p53 temperature-dependent mutants and their reactivation by amifostine in yeast

Grochová, D., Vaňková, J., Damborský, J., Ravčuková, B., Šmarda, J., Vojtěšek, B., & Šmardová, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210748 · Cited by 25

Binding of Amphipathic Cell Penetrating Peptide p28 to Wild Type and Mutated p53 as studied by Raman, Atomic Force and Surface Plasmon Resonance spectroscopies

Signorelli, S., Santini, S., Yamada, T., Bizzarri, A. R., Beattie, C. W., & Cannistraro, S. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.01.022 · Cited by 25

The RNF20/40 complex regulates p53-dependent gene transcription and mRNA splicing

Wu, C., Cui, Y., Liu, X., Zhang, F., Lu, L., & Yu, X. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz045 · Cited by 25

The Lys-Specific Molecular Tweezer, CLR01, Modulates Aggregation of the Mutant p53 DNA Binding Domain and Inhibits Its Toxicity

Herzog, G., Shmueli, M. D., Levy-Kanfo, L., Engel, L., Gazit, E., Klärner, F., Schrader, T. H., Bitan, G., & Segal, D. (2015) · Biochemistry · doi:10.1021/bi501092p · Cited by 25

p53 status correlates with the differential expression of the DNA mismatch repair protein MSH2 in non‐small cell lung carcinoma

Xinarianos, G., Liloglou, T., Prime, W., Sourvinos, G., Karachristos, A., Gosney, J. R., Spandidos, D. A., & Field, J. K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10598 · Cited by 25

Influence of GSTM1, GSTT1, GSTP1 and NAT2 genotypes on the p53 mutational spectrum in bladder tumours

Ryk, C., Berggren, P., Kumar, R., Hemminki, K., Larsson, P., Steineck, G., Lambert, B., & Hou, S. (2004) · International Journal of Cancer · doi:10.1002/ijc.20650 · Cited by 25

Polymorphisms in drug metabolism genes, smoking, and p53 mutations in breast cancer

Emburgh, B. O. V., Hu, J. J., Levine, E. A., Mosley, L. J., Case, L. D., Lin, H., Knight, S. N., Perrier, N. D., Rubin, P., Sherrill, G. B., et al. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20365 · Cited by 25

Association of the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis

Gonçalves, M. L., Borja, S. M., Leão-Cordeiro, J. A. B., Saddi, V. A., Ayres, F. M., Vilanova-Costa, C. A. S. T., & Silva, A. M. T. C. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-749 · Cited by 24

Low prevalence of p53, p16INK4aand Ha-ras tumour-specific mutations in low-graded actinic keratosis

Nindl, I., Gottschling, M., Krawtchenko, N., Lehmann, M., Röwert‐Huber, J., Eberle, J., Stockfleth, E., & Forschner, T. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07857.x · Cited by 24

Mcph1/Brit1 deficiency promotes genomic instability and tumor formation in a mouse model

Liang, Y., Gao, H., Lin, S.-Y., Goss, J. A., Du, C., & Li, K. (2014) · Oncogene · doi:10.1038/onc.2014.367 · Cited by 24

Early occurrence of lung adenocarcinoma and breast cancer after radiotherapy of a chest wall sarcoma in a patient with a de novo germline mutation in TP53

Ferrarini, A., Auteri-Kaczmarek, A., Pica, A., Boesch, N., Heinimann, K., Schäfer, S. C., Mégalo, S. V., Cina, V., Beckmann, J. S., & Monnerat, C. (2011) · Familial Cancer · doi:10.1007/s10689-010-9415-9 · Cited by 24

Fishing for Intestinal Cancer Models: Unraveling Gastrointestinal Homeostasis and Tumorigenesis in Zebrafish

Faro, A., Boj, S. F., & Clevers, H. C. (2009) · Zebrafish · doi:10.1089/zeb.2009.0617 · Cited by 24

Clinical Applications of Microarray-Based Diagnostic Tests

Wu, L., Williams, P. M., & Koch, W. H. (2005) · BioTechniques · doi:10.2144/000112046 · Cited by 24

Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancer

Trivedi, S., Rosen, C. A., & Ferris, R. L. (2016) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0000000000000245 · Cited by 24

Promoter Hypermethylation of the DNA-Repair Gene O 6 -Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma

Hiraga, J., Kinoshita, T., Ohno, T., Mori, N., Ohashi, H., Fukami, S., Noda, A., Ichikawa, A., & Naoe, T. (2006) · International Journal of Hematology · doi:10.1532/ijh97.06087 · Cited by 24

DNA-damage sensitizers: Potential new therapeutical tools to improve chemotherapy

Michod, D., & Widmann, C. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.04.003 · Cited by 24

A WORKFLOW FOR MUTATION EXTRACTION AND STRUCTURE ANNOTATION

Kanagasabai, R., Choo, K. H., Ranganathan, S., & Baker, C. J. O. (2007) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720007003119 · Cited by 24

The Environmental and Human Effects of Ptaquiloside-Induced Enzootic Bovine Hematuria: A Tumorous Disease of Cattle

Sharma, R., Bhat, T. K., & Sharma, O. P. (2012) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/978-1-4614-5882-1_3 · Cited by 24

TP53 codon 72 polymorphism and risk of conjunctival squamous cell carcinoma in Uganda

Tornesello, M. L., Waddell, K. M., Duraturo, M. L., Biryahwaho, B., Downing, R. G., Lucas, S. B., Giani, U., Buonaguro, L., & Buonaguro, F. M. (2005) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2005.08.003 · Cited by 24

Predicting the transactivation activity of p53 missense mutants using a four-body potential score derived from Delaunay tessellations

Mathé, E. A., Olivier, M., Kato, S., Ishioka, C., Vaisman, I. I., & Hainaut, P. L. (2006) · Human Mutation · doi:10.1002/humu.20284 · Cited by 24

Mutation spectrum in UVB‐exposed skin epidermis of Xpa‐knockout mice: Frequent recovery of triplet mutations

Ikehata, H., Yanase, F., Mori, T., Nikaido, O., Tanaka, K., & Ono, T. (2006) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20262 · Cited by 24

TP53 codon 72 polymorphism and P53 protein expression in colorectal cancer specimens in Isfahan.

Dastjerdi, M. N. (2011) · PubMed · Cited by 24

Induction of apoptosis in cancer cells through N-acetyl-l-leucine-modified polyethylenimine-mediated p53 gene delivery

Li, Z., Zhang, L., & Li, Q. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.08.024 · Cited by 23

Interaction between p53 codon 72 polymorphism and melanocortin 1 receptor variants on suntan response and cutaneous melanoma risk

Nan, H., Qureshi, A. A., Hunter, D. J., & Han, J. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08624.x · Cited by 23

PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: a requirement for Akt down-regulation

Kobayashi, N., Abedini, M. R., Sakuragi, N., & Tsang, B. K. (2013) · Journal of Ovarian Research · doi:10.1186/1757-2215-6-7 · Cited by 24

Dynamic perspectives into the mechanisms of mutation‐induced p53‐DNA binding loss and inactivation using active perturbation theory: Structural and molecular insights toward the design of potent reactivators in cancer therapy

Olotu, F. A., & Soliman, M. E. S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27458 · Cited by 23

Thrombin

Maragoudakis, M. E., & Tsopanoglou, N. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09637-7 · Cited by 32

Using small molecules to overcome drug resistance induced by a viral oncogene

Smukste, I., Bhalala, O. G., Persico, M., & Stockwell, B. R. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.012 · Cited by 23

A Fluid Salt-bridging Cluster and the Stabilization of p53

Lwin, T. Z., Durant, J. J., & Bashford, D. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.07.080 · Cited by 23

Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.

Baumbusch, L. O., Myhre, S., Langerød, A., Bergamaschi, A., Geisler, S. B., Lønning, P. E., Deppert, W., Dornreiter, I., & Børresen‐Dale, A. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-47 · Cited by 23

Stabilising the DNA-binding domain of p53 by rational design of its hydrophobic core

Khoo, K., Joerger, A. C., Freund, S. M. V., & Fersht, A. R. (2009) · Protein Engineering Design and Selection · doi:10.1093/protein/gzp018 · Cited by 26

TAp73α Increases p53 Tumor Suppressor Activity in Thyroid Cancer Cells via the Inhibition of Mdm2-Mediated Degradation

Malaguarnera, R., Vella, V., Pandini, G., Sanfilippo, M., PEZZINO, V., Vigneri, R., & Frasca, F. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0005 · Cited by 23

Variations in sensitivity to ionizing radiation in relation to p53 mutation point.

Okaichi, K., Ide-Kanematsu, M., Izumi, N., MORITA, N. I., Okumura, Y., & Ihara, M. (2008) · PubMed · Cited by 23

The Cancer-associated K351N Mutation Affects the Ubiquitination and the Translocation to Mitochondria of p53 Protein

Muscolini, M., Montagni, E., Palermo, V., Agostino, S. D., Gu, W., Abdelmoula-Souissi, S., Mazzoni, C., Blandino, G., & Tuosto, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.279539 · Cited by 23

Prediction of protein stability changes upon single-point variant using 3D structure profile

Gong, J., Wang, J., Zong, X., Ma, Z., & Xu, D. H. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.12.008 · Cited by 22

Somatic microindels: analysis in mouse soma and comparison with the human germline

Hagman, K. D. F., Hill, K. A., Li, K., Li, W., Scaringe, W. A., Wang, J., Gu, D., & Sommer, S. S. (2006) · Human Mutation · doi:10.1002/humu.20416 · Cited by 23

Papillary and muscle invasive bladder tumors with distinct genomic stability profiles have different DNA repair fidelity and KU DNA‐binding activities

Bentley, J., L’Hôte, C., Platt, F. M., Hurst, C. D., Lowery, J., Taylor, C., Sak, S. C., Harnden, P., Knowles, M. A., & Kiltie, A. E. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20641 · Cited by 22

Molecular characterization of head and neck cancer: how close to personalized targeted therapy?

Worsham, M. J., Ali, H. Y., Dragovic, J., & Schweitzer, V. P. (2012) · PubMed · doi:10.2165/11635330-000000000-00000 · Cited by 22

Haplotype analysis of p53 polymorphisms: Arg72Pro, Ins16bp and G13964C in Tunisian patients with familial or sporadic breast cancer

Trifa, F., Karray-Chouayekh, S., Mabrouk, I., Baccouche, S., Khabir, A., Sellami‐Boudawara, T., Gargouri, A. F., & Mokdad‐Gargouri, R. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.02.007 · Cited by 22

Novel tools for extraction and validation of disease-related mutations applied to fabry disease

Kuipers, R. K. P., van den Bergh, T., Joosten, H., Deprez, R. H. L., Mannens, M. M. A. M., & Schaap, P. J. (2010) · Human Mutation · doi:10.1002/humu.21317 · Cited by 22

Use of p53 for therapy of human cancer

Almazov, V. P., Кочетков, Д. В., & Chumakov, P. M. (2007) · Molecular Biology · doi:10.1134/s0026893307060015 · Cited by 22

Effect of the p53 Codon 72 and Intron 3Polymorphisms on Non-Small Cell Lung Cancer (NSCLC) Prognosis

Boldrini, L., Gisfredi, S., Ursino, S., Lucchi, M., Greco, G., Mussi, A., Donati, V. L., & Fontanini, G. (2008) · Cancer Investigation · doi:10.1080/07357900701788023 · Cited by 22

BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area

Eachkoti, R., Hussain, I., Afroze, D., AejazAziz, S., Jan, M., Shah, Z. A., Das, B. C., & Siddiqi, M. A. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.08.012 · Cited by 22

P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan

Saleem, S., Azhar, A., Hameed, A., Khan, M. A., Abbasi, Z. A., Qureshi, N. R., & Ajmal, M. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.04.004 · Cited by 22

Evaluation of Oligonucleotide Arrays for Sequencing of the p53 Gene in DNA from Formalin-Fixed, Paraffin-Embedded Breast Cancer Specimens

Cooper, M., Li, S.-Q., Bhardwaj, T., Rohan, T. E., & Kandel, R. A. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.025221 · Cited by 22

Narrative review of challenges in the management of advanced neuroendocrine prostate cancer

Okasho, K., Ogawa, O., & Akamatsu, S. (2021) · Translational Andrology and Urology · doi:10.21037/tau-20-1131 · Cited by 21

FOXO transcription factors differ in their dynamics and intra/intermolecular interactions

Spreitzer, E., Alderson, T. R., Bourgeois, B. M. R., Eggenreich, L., Habacher, H., Bramerdorfer, G., Pritišanac, I., Sánchez‐Murcia, P. A., & Madl, T. (2022) · Current Research in Structural Biology · doi:10.1016/j.crstbi.2022.04.001 · Cited by 21

Post-Translational Modifications of p53 in Ferroptosis: Novel Pharmacological Targets for Cancer Therapy

Zhang, L., Hou, N., Chen, B., Kan, C., Han, F., Zhang, J., & Sun, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.908772 · Cited by 21

The p53 Codon 72 Pro/Pro Genotype Identifies Poor-Prognosis Neuroblastoma Patients: Correlation with Reduced Apoptosis and Enhanced Senescence by the p53-72P Isoform

Cattelani, S., Ferrari‐Amorotti, G., Galavotti, S., Defferrari, R., Tanno, B., Cialfi, S., Vergalli, J., Fragliasso, V., Guerzoni, C., Manzotti, G., et al. (2012) · Neoplasia · doi:10.1593/neo.12594 · Cited by 21

Synergistic decline in expressions of p73 and p21 with invasion in esophageal cancers

Masuda, N., Kato, H., Nakajima, T., Sano, T., Kashiwabara, K., Oyama, T., & Kuwano, H. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01491.x · Cited by 21

RHAMM splice variants confer radiosensitivity in human breast cancer cell lines

Schütze, A., Vogeley, C., Gorges, T. M., Twarock, S., Butschan, J., Babayan, A., Klein, D., Knauer, S. K., Metzen, E., Müller, V., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7258 · Cited by 22

Data resources for the identification and interpretation of actionable mutations by clinicians

Prawira, A., Pugh, T. J., Stockley, T. L., & Siu, L. L. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx023 · Cited by 23

The management of localized esophageal squamous cell carcinoma: Western approach

Zaidi, N., & Kelly, R. J. (2017) · Chinese Clinical Oncology · doi:10.21037/cco.2017.07.07 · Cited by 22

Acrolein contributes to urothelial carcinomas in patients with chronic kidney disease

Hong, J., Lee, P. A. H., Lu, Y.-C., Huang, C.-Y., Chen, C., Chiang, C.-H., Chow, P., Jaw, F.-S., Wang, C., Huang, C., et al. (2020) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2020.02.017 · Cited by 21

Exome sequencing identifies new somatic alterations and mutation patterns of tongue squamous cell carcinoma in a Chinese population

Zhang, H., Song, Y., Du, Z., Li, X., Zhang, J., Chen, S., Chen, F., Li, T., & Zhan, Q. (2020) · The Journal of Pathology · doi:10.1002/path.5467 · Cited by 21

Protoflavone-Chalcone Hybrids Exhibit Enhanced Antitumor Action through Modulating Redox Balance, Depolarizing the Mitochondrial Membrane, and Inhibiting ATR-Dependent Signaling

Latif, A. D., Jernei, T., Podolski-Renić, A., Kuo, C., Vágvölgyi, M., Girst, G., Zupkó, I., Develi, S., Ulukaya, E., Wang, H., et al. (2020) · Antioxidants · doi:10.3390/antiox9060519 · Cited by 21

KRAS and TP53 mutations in colorectal carcinoma

Al-Kuraya, K. S. (2009) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.56087 · Cited by 21

Preservation of RNA for functional analysis of separated alleles in yeast: comparison of snap-frozen and RNALater® solid tissue storage methods

Dekairelle, A., der Vorst, S. V., TOMBAL, B. F., & Gala, J. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.281 · Cited by 21

Prognostic significance of p53 gene mutations and protein overexpression in localized gastrointestinal stromal tumours

Ryu, M., Kang, Y., Jang, S. J., Kim, T. W., Lee, H., Kim, J.-S., Park, Y. H., Lee, S. S., Ryoo, B., Chang, H. M., et al. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02797.x · Cited by 21

Mutation spectrum in UVB-exposed skin epidermis of a mildly-affectedXpg-deficient mouse

Wang, F., Saito, Y., Shiomi, T., Yamada, S., Ono, T., & Ikehata, H. (2005) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20173 · Cited by 21

Molecular Characterization of Head and Neck Cancer

Worsham, M. J., Ali, H. Y., Dragovic, J., & Schweitzer, V. P. (2012) · Molecular Diagnosis & Therapy · doi:10.1007/bf03262210 · Cited by 20

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival

Kringen, P., Wang, Y., Dumeaux, V., Nesland, J., Kristensen, G., Børresen-Dale, A., & Dørum, A. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-134 · Cited by 17

Stability of the core domain of p53: insights from computer simulations

Madhumalar, A., Smith, D. J., & Verma, C. S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-s1-s17 · Cited by 20

The potential of molecular markers to improve interventions through the natural history of oesophageal squamous cell carcinoma

Costa, N. M. D., Lima, S. C. S., Simão, T. D. A., & Pinto, L. F. R. (2013) · Bioscience Reports · doi:10.1042/bsr20130063 · Cited by 20

Identification & Characterization of lactobacillus salavarius bacteriocins and its relevance in cancer therapeutics

Shaikh, F., Abhinand, P. A., & Ragunath, P. (2012) · Bioinformation · doi:10.6026/97320630008589 · Cited by 20

Frequency of TP53 Mutations in Relation to Arg72Pro Genotypes in Non–Small Cell Lung Cancer

Lind, H., Ekstrøm, P. O., Ryberg, D., Skaug, V., Andreassen, T., Stangeland, L. B., Haugen, A., & Zienolddiny, S. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0153 · Cited by 20

Oncogenomic Approaches in Exploring Gain of Function of Mutant p53

Donzelli, S., Biagioni, F., Fausti, F., Strano, S., Fontemaggi, G., & Blandino, G. (2008) · Current Genomics · doi:10.2174/138920208784340713 · Cited by 22

TP53 genetic alterations in Arab breast cancer patients: Novel mutations, pattern and distribution

Al-Qasem, A. J., Toulimat, M., Eldali, A., Tulbah, A. M., Al‐Yousef, N., Al-Daihan, S., Tassan, N. A. A., Al‐Tweigeri, T., & Aboussekhra, A. (2011) · Oncology Letters · doi:10.3892/ol.2011.236 · Cited by 20

LincRNAs and base modifications of p53 induced by arsenic methylation in workers

Wen, W., Lü, L., He, Y., Cheng, H., He, F., Cao, S., Li, L., Li, X., & Wu, T. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.01.003 · Cited by 20

Benzo[a]pyrene, Aflatoxine B1 and Acetaldehyde Mutational Patterns in TP53 Gene Using a Functional Assay: Relevance to Human Cancer Aetiology

Paget, V., Lechevrel, M., André, V., Goff, J. L., Pottier, D., Billet, S., Garçon, G., Shirali, P., & Sichel, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030921 · Cited by 20

Effects of Stability on the Biological Function of p53

Khoo, K. H., Mayer, S., & Fersht, A. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033183 · Cited by 20

Micromanagement of the mitochondrial apoptotic pathway by p53

Walia, V. (2010) · Frontiers in bioscience · doi:10.2741/3717 · Cited by 20

Clinical implications of p53 mutation analysis in bladder cancer tissue and urine sediment by functional assay in yeast

Schlichtholz, B. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh256 · Cited by 20

Colorectal carcinoma prognosis can be predicted by alterations in gene p53 exons 5 and 8

Vidaurreta, M., Maestro, M. L., Casla, M. T. S., Rafael, S., Veganzones, S., de la Orden, V., Cerdán, J., Arroyo, M., & Torres, A. (2008) · International Journal of Colorectal Disease · doi:10.1007/s00384-008-0454-8 · Cited by 20

p53 controls hPar1 function and expression

Salah, Z., Haupt, S., Maoz, M., Baraz, L., Rotter, V., Peretz, T., Haupt, Y., & Bar‐Shavit, R. (2008) · Oncogene · doi:10.1038/onc.2008.324 · Cited by 20

Web services and workflow management for biological resources

Romano, P. D., Marra, D., & Milanesi, L. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-s4-s24 · Cited by 20

FANCI functions as a repair/apoptosis switch in response to DNA crosslinks

Shah, R. B., Kernan, J. L., van Hoogstraten, A., Ando, K., Li, Y., Belcher, A. L., Mininger, I., Bussenault, A. M., Raman, R., Ramanagoudr‐Bhojappa, R., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.06.010 · Cited by 20

Subsets of cancer cells expressing CX3CR1 are endowed with metastasis-initiating properties and resistance to chemotherapy

DiNatale, A., Kaur, R., Chen, Q., Zhang, J., Marchioli, M., Ipe, D., Castelli, S., McNair, C. M., Kumar, G., Meucci, O., et al. (2022) · Oncogene · doi:10.1038/s41388-021-02174-w · Cited by 21

Intrinsically Disordered N-terminal Domain (NTD) of p53 Interacts with Mitochondrial PTP Regulator Cyclophilin D

Zhao, J., Liu, X., Blayney, A. J., Zhang, Y., Gandy, L. A., Mirsky, P. O., Smith, N. S., Zhang, F., Linhardt, R. J., Chen, J., et al. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167552 · Cited by 19

Heterogeneous biomedical database integration using a hybrid strategy: a p53 cancer research database.

Bichutskiy, V. Y., Colman, R., Brachmann, R. K., & Lathrop, R. H. (2007) · PubMed Central · Cited by 19

Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population.

Ru, J., Cong, Y., Kang, W., Yu, L., Guo, T., & Zhao, J. (2015) · PubMed Central · Cited by 19

TP53 Gene Pro72Arg (rs1042522) Single Nucleotide Polymorphism as Not a Risk Factor for Colorectal Cancer in the Iranian Azari Population

Asadi, M., Shanehbandi, D., Zarrintan, A., Pedram, N., Baradaran, B., Zafari, V., Shirmohamadi, M., & hashemzadeh, S. (2017) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2017.18.12.3423 · Cited by 19

Directed Evolution of p53 Variants with Altered DNA-binding Specificities by In Vitro Compartmentalization

Fen, C. X., Coomber, D., Lane, D. P., & Ghadessy, F. J. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.099 · Cited by 19

MutationView/KMcancerDB: A database for cancer gene mutations

Shimizu, N., Ohtsubo, M., & Minoshima, S. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00405.x · Cited by 19

Increased Risk of Colorectal Adenomas in Italian Subjects Carrying the p53 PIN3 A2-Pro72 Haplotype

Perfumo, C., Bonelli, L. A., Menichini, P., Inga, A., Gismondi, V., Ciferri, E., Percivale, P., Bianchi‐Scarrà, G., Nasti, S., Fronza, G., et al. (2006) · Digestion · doi:10.1159/000100966 · Cited by 20

Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells

Wergeland, L., Sjøholt, G., Haaland, I., Hovland, R., Bruserud, Ø., & Gjertsen, B. T. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-33 · Cited by 18

Investigating the role of human papillomavirus in squamous cell carcinoma of the temporal bone

Masterson, L. M., Winder, D. M., Marker, A. J., Sterling, J., Sudhoff, H. H., Moffat, D. A., & Goon, P. (2013) · Cited by 19

[The use of p53 as a tool for human cancer therapy].

Almazov, V. P., Кочетков, Д. В., & Chumakov, P. M. (2007) · PubMed · Cited by 20

Limits to the Human Cancer Genome Project?

Chng, W. J. (2007) · Science · doi:10.1126/science.315.5813.762b · Cited by 19

Lung specific expression of a human mutant p53 affects cell proliferation in transgenic mice

Duan, W., Gao, L., Jin, D., Otterson, G. A., & Villalona-Calero, M. A. (2007) · Transgenic Research · doi:10.1007/s11248-007-9154-3 · Cited by 18

Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells

Okagawa, Y., Takada, K., Arihara, Y., Kikuchi, S., Osuga, T., Nakamura, H., Kamihara, Y., Hayasaka, N., Usami, M., Murase, K., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168355 · Cited by 18

O-GlcNAcylation in women’s cancers: breast, endometrial and ovarian

Trinca, G. M., & Hagan, C. R. (2017) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-017-9730-z · Cited by 18

From Bench to Bedside and Beyond: Therapeutic Scenario in Acute Myeloid Leukemia

Gurnari, C., Voso, M. T., Maciejewski, J. P., & Visconte, V. (2020) · Cancers · doi:10.3390/cancers12020357 · Cited by 18

POMC and TP53 genetic variability and risk of basal cell carcinoma of skin: Interaction between host and genetic factors

Rizzato, C., Scherer, D., Rudnai, P., Gurzau, E. S., Koppová, K., Hemminki, K., Canzian, F., Kumar, R., & Campa, D. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2011.03.006 · Cited by 18

Frequent occurrence of gastric cancer in Asian kindreds with Li–Fraumeni syndrome

Ariffin, H., Chan, A. S. L., Oh, L., Abd-Ghafar, S., Ong, G. B., Mohamed, M. B., Razali, H., Juraida, E., Teo, S., Karsa, M., et al. (2014) · Clinical Genetics · doi:10.1111/cge.12525 · Cited by 18

Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation

Vivo, C., Boulangé-Lecomte, C., Levy, F., Leroy, K., Kirova, Y., Renier, A., Kheuang, L., Piedbois, P., Chopin, D. K., & Jaurand, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600736 · Cited by 18

Gain-of-Function Mutant TP53 R248Q Overexpressed in Epithelial Ovarian Carcinoma Alters AKT-Dependent Regulation of Intercellular Trafficking in Responses to EGFR/MDM2 Inhibitor

Tsai, K.-Y., Lai, Z., Chang, S., & Chuang, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168784 · Cited by 18

Potential of rescue and reactivation of tumor suppressor p53 for cancer therapy

Hibino, E., & Hiroaki, H. (2022) · Biophysical Reviews · doi:10.1007/s12551-021-00915-5 · Cited by 17

Bioinformatic Challenges Detecting Genetic Variation in Precision Medicine Programs

Field, M. A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.806696 · Cited by 19

The IARC TP53 mutation database: a resource for studying the significance of TP53 mutations in human cancers

Olivier, M., Hainaut, P. L., & Petitjean, A. (2007) · IATREIA

IARC TP53 Database

Olivier, M., & Hainaut, P. L. (2008) · Springer eBooks · doi:10.1007/978-3-540-47648-1_2934 · Cited by 1

Untitled work

(1999) · doi:10.1002/(sici)1098-1004(1999)14:1

TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data: Human Mutation

Bouaoun, L., Sonkin, D., Ardin, M., Hollstein, M., Byrnes, G., Zavadil, J., & Olivier, M. (2016) · Human Mutation · doi:10.1002/humu.23035 · Cited by 730

Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects

Hainaut, P. L., Soussi, T., Shomer, B., Hollstein, M. C., Greenblatt, M. S., Hovig, E. J., Harris, C. C., & Montesano, R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.1.151 · Cited by 299